{"disease":{"id":"advanced-stage-cancer-solid-tumor-disease-for-4-patients","name":"advanced stage cancer solid tumor disease for 4 patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03420430","title":"Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Genelux Corporation","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}